CYP 2.81% $1.21 cynata therapeutics limited

New director

  1. 1,070 Posts.
    lightbulb Created with Sketch. 151
    Id like to get the opinions of others with regards to the appointment of a new director.
    As we are very much bound up with Japan/Asia it seems a market savvy well connected Asian director could well assist with the promotion of Cynata both at a stock level and business development.

    if you refer back to the AGM presentation 15.11.2018

    page confidential discussions..

    non binding term sheets with MULTIPLE partners..

    page 18 ...PMDA japan early 2019.

    page 33 CRS...nasdaq FATE as per Star investing article.

    page 36...with or without fuji....!!

    all this was 6 months ago..clearly things
    must have moved forward despite the lack of team say we can be fairly sure that in 6 months term sheets have been signed???

    A new Asian board director with network connections to die for could well help!!!

    what about the Li Ka Shing gene and cell therapy
    centre connection with prof Rasco..LKS were looking for a deal..did they find one??


    1. I agree a bigger better deal.Maybe a new entity much higher cap value emerging..fuji/cynata/another

    2. We have all the frogspawn we need and fuji in any case are bound by the cynata/ cdi agreement.

    we need a new impetus on this board..but need to keep a steady ship as we head to an explosive capital Growth.

watchlist Created with Sketch. Add CYP (ASX) to my watchlist
(20min delay)
Mkt cap ! $123.2M
Open High Low Value Volume
$1.23 $1.25 $1.21 $41.80K 33.80K

Buyers (Bids)

No. Vol. Price($)
1 3852 $1.21

Sellers (Offers)

Price($) Vol. No.
$1.25 17909 2
View Market Depth
Last update - 16.10pm 19/04/2019 (20 minute delay) ?
-0.035 ( 2.02 %)
Open High Low Volume
$1.23 $1.24 $1.21 8867
Last updated 15.59pm 19/04/2019 (live) ?
CYP (ASX) Chart
GET SUPPORT arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.